Skip to main content

International Vaccine Access Center

Featured

Thumbnail for 2024 event

Watch: "Celebrating Vaccine Victories: EPI at 50"

View our webinar commemorating World Immunization Week 2024.

Profile picture of Lois Privor-Dumm, a profressor at IVAC, JHU

Celebrating the Public Health Career of Lois Privor-Dumm

Lois Privor-Dumm reflects on her career at IVAC.

Thumnail of case study publication detailing how to improve access to PCV and RVV vaccines

Case Study: Accelerating Vaccine Access in a Post COVID-19 Environment

The case study provides insight on overcoming challenges and optimizing vaccine rollouts.

Vaccine vials

Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

IVAC's Work

The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.

Where We Work

 IVAC works with governments and major research institutions in 38 countries. Learn more about us.

World map identifying countries where IVAC currently has projects

What We Do: Project Highlights

Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>

Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >

More Projects

Stay Connected

Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.